Instituut voor Hyperbare Geneeskunde B.V.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Instituut voor Hyperbare Geneeskunde B.V. - overview
Established
1996
Location
Rotterdam, -, Netherlands
Primary Industry
Healthcare
About
Based in Rotterdam, Netherlands, and founded in 1996, Instituut voor Hyperbare Geneeskunde B. V. , doing business as IvHG, is a medical specialist institution specializing in hyperbaric oxygen therapy. The firm has treatment centres in Arnhem, Hoogeveen, Waalwijk, Rotterdam and Maarssen.
In May 2018, Excellent Clinics B. V. , a portfolio company of Gimv, acquired IvHG from BB Capital Investments. The firm enables patients with radiation-induced tissue damage, complex wounds, and chronic bone inflammation to receive hyperbaric oxygen therapy.
The firm also provides mobility services to patients in areas where hyperbaric oxygen therapy is not available.
Current Investors
Gimv, Excellent Clinics B.V.
Primary Industry
Healthcare
Sub Industries
Clinics/Outpatient Services, Diagnostic, Medical & Imaging Laboratories, Chiropractic, Orthopedic & Physical Therapy
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Instituut voor Hyperbare Geneeskunde B.V. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, Trade Sale | Completed | Instituut voor Hyperbare Geneeskunde B.V. | - | ||||||||
| Buyout | Completed | Instituut voor Hyperbare Geneeskunde B.V. | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.